RHYTHM PHARMACEUTICALS INC

For the period ended Dec 31, 2023. Filed Feb 29, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 29, 2024

RYTM$113.94+1.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share data)


· · December 31, · · December 31,
	2023		2022

Assets
Current assets: · ·
Cash and cash equivalents		$60,081		$127,677
Short-term investments		215,765		205,611
Accounts receivable, net		14,867		6,224
Inventory		8,624		2,917
Prepaid expenses and other current assets		8,931		11,807
Total current assets		308,268		354,236
Property and equipment, net		1,341		2,197
Right-of-use asset		781		1,182
Intangible assets, net		7,028		7,883
Restricted cash		328		328
Other long-term assets		14,999		16,655
Total assets		$332,745		$382,481
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable		$4,885		$4,797
Accrued expenses and other current liabilities		48,262		32,894
Deferred revenue		1,286		1,434
Lease liability		770		684
Total current liabilities		55,203		39,809
Long-term liabilities:
Deferred royalty obligation		106,143		75,810
Lease liability, non-current		490		1,260
Derivative liability		1,150		1,340
Total liabilities		162,986		118,219
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred Stock, $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2023 and December 31, 2022		—		—
Common stock, $0.001 par value: 120,000,000 shares authorized; 59,426,559 and 56,612,429 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively		59		56
Additional paid-in capital		1,064,302		974,356
Accumulated other comprehensive income (loss)		134		(92)
Accumulated deficit		(894,736)		(710,058)
Total stockholders’ equity		169,759		264,262
Total liabilities and stockholders’ equity		$332,745		$382,481

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.